Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 17, 2025

October 17, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

October 17, 2025

4DMT Announces New Employment Inducement Grants

GlobeNewswire

October 17, 2025

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

GlobeNewswire

October 17, 2025

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

October 17, 2025

Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030

GlobeNewswire

October 17, 2025

ORYZON Receives Feedback From the FDA in Response to the Submitted Phase III Protocol in Borderline Personality Disorder

GlobeNewswire

October 17, 2025

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

GlobeNewswire

October 17, 2025

Wake Radiology Grows Breast Imaging Section with Five New Hires; Launches "We See the Difference" Campaign for Breast Cancer Awareness Month

GlobeNewswire

October 17, 2025

Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer

GlobeNewswire

October 17, 2025

Zealand Pharma major shareholder announcement: Van Herk Investments B.V.

GlobeNewswire

October 17, 2025

Dr. Alyssa Dweck Shares Menopause Insights and Solutions on YourUpdateTV

GlobeNewswire

October 17, 2025

Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke

GlobeNewswire

October 17, 2025

Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025

GlobeNewswire

October 17, 2025

Boehringer’s zongertinib demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC

GlobeNewswire

October 17, 2025

Corvus Pharmaceuticals Announces Presentation of Interim Data from the Phase 1b/2 Clinical Trial of Ciforadenant for Patients with Metastatic Renal Cell Cancer at the European Society for Medical Oncology (ESMO) Congress 2025

GlobeNewswire

October 17, 2025

Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement

GlobeNewswire

October 17, 2025

Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025

GlobeNewswire

October 17, 2025

WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage

GlobeNewswire

October 17, 2025

Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week

GlobeNewswire

October 17, 2025

Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show

GlobeNewswire